{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie aversive : Questions médicales les plus fréquentes",
"headline": "Thérapie aversive : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie aversive : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie aversive"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapie comportementale",
"url": "https://questionsmedicales.fr/mesh/D001521",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale",
"code": {
"@type": "MedicalCode",
"code": "D001521",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thérapie aversive",
"alternateName": "Aversive Therapy",
"code": {
"@type": "MedicalCode",
"code": "D001348",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Morten Moshagen",
"url": "https://questionsmedicales.fr/author/Morten%20Moshagen",
"affiliation": {
"@type": "Organization",
"name": "Ulm University, Albert-Einstein-Allee 47, 89081, Ulm, Germany."
}
},
{
"@type": "Person",
"name": "Benjamin E Hilbig",
"url": "https://questionsmedicales.fr/author/Benjamin%20E%20Hilbig",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, RPTU Kaiserslautern-Landau, Fortstr. 7, 76829, Landau, Germany."
}
},
{
"@type": "Person",
"name": "Erich Seifritz",
"url": "https://questionsmedicales.fr/author/Erich%20Seifritz",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland."
}
},
{
"@type": "Person",
"name": "Adrien T Stanley",
"url": "https://questionsmedicales.fr/author/Adrien%20T%20Stanley",
"affiliation": {
"@type": "Organization",
"name": "Departments of Biology and Psychiatry, Columbia University, New York, NY, United States."
}
},
{
"@type": "Person",
"name": "David Sulzer",
"url": "https://questionsmedicales.fr/author/David%20Sulzer",
"affiliation": {
"@type": "Organization",
"name": "Departments of Psychiatry, Neurology, and Pharmacology, Columbia University Medical Center, New York, NY, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Colchicine as a Modulator of Platelet Function: A Systematic Review.",
"datePublished": "2022-07-26",
"url": "https://questionsmedicales.fr/article/35882248",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1749660"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Insight into Recent Advances on Platelet Function in Health and Disease.",
"datePublished": "2022-05-27",
"url": "https://questionsmedicales.fr/article/35682700",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23116022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential inhibition of platelet function by cilostazol in combination with clopidogrel.",
"datePublished": "2023-09-23",
"url": "https://questionsmedicales.fr/article/37740121",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00228-023-03553-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/35770723",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jth.15781"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical Outcomes of Individualized Antiplatelet Therapy Based on Platelet Function Test in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.",
"datePublished": "2023-04-01",
"url": "https://questionsmedicales.fr/article/36651931",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/FJC.0000000000001393"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thérapie aversive",
"item": "https://questionsmedicales.fr/mesh/D001348"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie aversive - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie aversive",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie aversive",
"description": "Comment diagnostiquer un besoin de thérapie aversive ?\nQuels tests sont utilisés pour évaluer les comportements ?\nQui peut prescrire une thérapie aversive ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie aversive est-elle adaptée à tous ?",
"url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Platelet+Function+Tests&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie aversive",
"description": "Quels symptômes indiquent un besoin de thérapie aversive ?\nComment se manifestent les comportements indésirables ?\nLes symptômes varient-ils selon les individus ?\nQuels effets émotionnels peuvent résulter de ces comportements ?\nLes symptômes physiques sont-ils liés à la thérapie aversive ?",
"url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Platelet+Function+Tests&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie aversive",
"description": "Comment prévenir les comportements indésirables ?\nLes interventions précoces sont-elles efficaces ?\nQuel rôle joue le soutien social dans la prévention ?\nLes programmes éducatifs sont-ils utiles ?\nComment la thérapie préventive est-elle mise en œuvre ?",
"url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Platelet+Function+Tests&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie aversive",
"description": "Comment fonctionne la thérapie aversive ?\nQuels types de stimuli sont utilisés ?\nLa thérapie aversive est-elle efficace ?\nCombien de séances sont généralement nécessaires ?\nY a-t-il des alternatives à la thérapie aversive ?",
"url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Platelet+Function+Tests&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie aversive",
"description": "Quelles complications peuvent survenir avec la thérapie aversive ?\nLa thérapie aversive peut-elle aggraver certains symptômes ?\nQuels sont les effets à long terme de cette thérapie ?\nComment gérer les complications éventuelles ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Platelet+Function+Tests&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie aversive",
"description": "Quels facteurs augmentent le risque de comportements indésirables ?\nLe stress est-il un facteur de risque ?\nLes troubles mentaux prédisposent-ils à la thérapie aversive ?\nL'isolement social est-il un facteur de risque ?\nLes antécédents de traumatismes influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Platelet+Function+Tests&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de thérapie aversive ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les comportements ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour l'évaluation."
}
},
{
"@type": "Question",
"name": "Qui peut prescrire une thérapie aversive ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychologue ou un psychiatre qualifié peut prescrire cette thérapie après évaluation."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence et l'intensité des comportements indésirables."
}
},
{
"@type": "Question",
"name": "La thérapie aversive est-elle adaptée à tous ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle n'est pas recommandée pour tous les patients, surtout ceux avec des troubles graves."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie aversive ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements compulsifs ou des addictions peuvent nécessiter cette thérapie."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les comportements indésirables ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par des actions répétitives nuisibles ou des dépendances."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'individu et de la situation."
}
},
{
"@type": "Question",
"name": "Quels effets émotionnels peuvent résulter de ces comportements ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les individus peuvent ressentir de la honte, de l'anxiété ou de la dépression."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils liés à la thérapie aversive ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes physiques peuvent apparaître en raison du stress lié aux comportements."
}
},
{
"@type": "Question",
"name": "Comment prévenir les comportements indésirables ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation et la sensibilisation aux conséquences des comportements peuvent aider à prévenir."
}
},
{
"@type": "Question",
"name": "Les interventions précoces sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interventions précoces peuvent réduire le développement de comportements problématiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le soutien social dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon soutien social peut aider à réduire les comportements indésirables en offrant des alternatives."
}
},
{
"@type": "Question",
"name": "Les programmes éducatifs sont-ils utiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent sensibiliser aux risques et aux conséquences des comportements indésirables."
}
},
{
"@type": "Question",
"name": "Comment la thérapie préventive est-elle mise en œuvre ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut inclure des séances de groupe ou des ateliers sur la gestion des comportements."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la thérapie aversive ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle associe un comportement indésirable à un stimulus désagréable pour réduire ce comportement."
}
},
{
"@type": "Question",
"name": "Quels types de stimuli sont utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des stimuli tels que des sons désagréables ou des sensations physiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La thérapie aversive est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace pour certains comportements, mais les résultats varient selon les individus."
}
},
{
"@type": "Question",
"name": "Combien de séances sont généralement nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais plusieurs semaines sont souvent nécessaires pour des résultats."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives à la thérapie aversive ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches comme la thérapie cognitivo-comportementale peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la thérapie aversive ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications émotionnelles comme l'anxiété ou la dépression peuvent survenir."
}
},
{
"@type": "Question",
"name": "La thérapie aversive peut-elle aggraver certains symptômes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des symptômes chez certains patients sensibles ou vulnérables."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme de cette thérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure une réduction des comportements, mais aussi des effets négatifs."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications éventuelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et un ajustement des techniques peuvent aider à gérer les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont pas systématiques, mais peuvent survenir selon la sensibilité du patient."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de comportements indésirables ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux de troubles mentaux et un environnement stressant peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer au développement de comportements indésirables."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux prédisposent-ils à la thérapie aversive ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles mentaux peuvent rendre la thérapie aversive plus nécessaire."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement social peut exacerber les comportements indésirables et les addictions."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes passés peuvent augmenter la probabilité de comportements problématiques."
}
}
]
}
]
}
The microtubule inhibitor and anti-inflammatory agent colchicine is used to treat a range of conditions involving inflammasome activation in monocytes and neutrophils, and is now known to prevent coro...
Platelets play a variety of roles in vascular biology and are best recognized as primary hemostasis and thrombosis mediators. Platelets have a large number of receptors and secretory molecules that ar...
To assess the antiplatelet effect of cilostazol clinically, we compared the effects of cilostazol in combination with clopidogrel on various platelet function tests....
We recruited patients with ischemic stroke at high risk of recurrence who were treated with clopidogrel alone within 180 days after stroke onset. Subjects underwent baseline platelet function tests, a...
Thirty-four patients were enrolled, but 4 patients were excluded for various reasons. In total, 30 subjects (13 in DAPT and 17 in SAPT group) were analyzed. Adenosine diphosphate- and collagen-induced...
The inhibitory effects of adjunctive cilostazol added to clopidogrel on platelet function differed by type of platelet function test. VerifyNow % inhibition and PRI were more inhibited than the other ...
CSPS.com substudy in TWMU (UMIN000026672), registered on April 1, 2017. This study was performed as a substudy of CSPS.com (UMIN000012180, registered on October 31, 2013) and was retrospectively regis...
Assessment of platelet secretion is crucial for diagnosing suspected inherited platelet function disorders (IPFD). A previous survey of the SSC on Platelet Physiology of the ISTH and a comprehensive r...
Platelet function test (PFT) is universally used to assess platelet reactivity to antiplatelet drugs in patients after percutaneous coronary intervention (PCI). However, it remains controversial wheth...
Patients with essential thrombocythaemia (ET) have an increased risk of thromboembolic events, which may differ according to different cytoreductive drugs. We investigated the effect of cytoreductive ...
Platelets play essential roles in the formation of blood clots by clumping with coagulation factors at the site of vascular injury to stop bleeding; therefore, a reduction in the platelet number or di...
To evaluate the effect of aspirin 80 mg compared to placebo on platelet function tests in the second and third trimester of pregnancy....
An explorative study was performed to assess laboratory platelet function in a subpopulation of the APRIL trial: a randomized double-blind trial comparing aspirin 80 mg once daily to placebo for the p...
We included 11 women, six in the aspirin and five in the placebo group. In women receiving aspirin, platelet function was significantly lower compared to women receiving placebo for all three tests: V...
Aspirin 80 mg has a clear inhibitory effect on laboratory platelet function during pregnancy compared to placebo. This effect is similar in the second and third trimester of pregnancy....
The influence of chimeric antigen receptor T (CAR-T) cell therapy on platelet function in relapsed/refractory (R/R) multiple myeloma (MM) has not been thoroughly investigated. Our cohort comprised fif...
This study aimed to establish in vitro hemodilution and resupplementation assays for obstetric hemorrhage in pregnancy-induced hypertension (PIH) and to monitor the coagulation function dynamically us...